Healthcare & Pharmaceuticals

Regulation, advancements in technology, and changes in demographics have made the healthcare industry one of most exciting and active industries in terms of M&A.  Characterized by consolidation, rising levels of international interest, and elevated valuations, the industry is drawing a great deal of investment across the healthcare spectrum from venture capitalists, private equity, and strategic acquirers.

Meridian professionals have deep expertise in the industry and an understanding of the opportunities available to many different industry participants ranging from medical products and devices to pharmaceuticals or healthcare technology to healthcare services.  As such, we welcome the opportunity to discuss industry trends, M&A dynamics, capital markets, and strategic transaction opportunities.

Healthcare & Pharmaceuticals Contacts

  • Patrick Ringland

    Patrick Ringland

    T: 206-224-6155
    E:
    hover to show bio

    Patrick joined Meridian Capital as a Vice President in 2011. At Meridian, Patrick works across a variety of industries providing financial analysis, valuation guidance, due diligence and transaction management. Before joining Meridian, Patrick worked as an associate for The Brattle Group in Cambridge, MA where he focused on valuation, corporate finance and tax strategy. He provided financial and economic consulting services to leading financial institutions, pharmaceutical companies and government agencies. Patrick also has experience working in M&A for the global advisory group of HSBC in London, UK.

    Patrick received his MBA with honors from the University of Chicago Booth School of Business and graduated from the University of Washington with a BS in Economics and a BA in Classical Studies.